Life Sciences

Legal strategies empowering life-changing innovation.

Our life sciences lawyers are trusted advisers to companies seeking to develop, market, monetize, and defend their innovative products, operations, and industry investments. We help navigate complex patent and regulatory issues; address novel AI and privacy considerations; advise on strategic alliances, acquisitions, and divestitures; and aggressively litigate disputes to advance our clients’ business goals.

Our life sciences lawyers serve 1,000+ industry companies across the pharmaceutical, biotechnology, medical device, veterinary, agricultural, and industrial life sciences sectors; nonprofit and academic research organizations; CROs and CMOs; and investment firms, venture capital companies, and lending institutions. We advise on:

  • Corporate and commercial transactions, including M&A, IPOs, spin-offs, joint ventures, strategic alliances, research platform deals, and development and commercialization collaborations
  • Pharmaceutical, controlled substance, nutraceutical, and medical device product regulatory strategies, approvals, and compliance in the United States and beyond, including orphan, expedited, and accelerated pathways, clinical testing, manufacturing and inspections, and enforcement actions such as warning letters, recalls, and consent decrees involving the FDA, USDA, DEA, and FTC
  • Complex commercial litigation and bet-the-company claims, including consumer class actions, post-M&A disputes, crisis management, product liability, trademark, copyright, trade secret, unfair competition, patent infringement and post-grant proceedings, Hatch-Waxman and biosimilar matters, and pay-for-delay and other antitrust challenges
  • IP issues spanning all facets of the patent procurement process, patent enforcement and defense of infringement claims, licensing, IP audits, and due diligence 
  • Life sciences-related financing transactions involving venture capital funds, private equity firms, investment and commercial banks, institutional lenders, and other investors
  • Exclusivity and product lifecycle issues, including regulatory and antitrust counseling and related competitor and government litigation
  • Drug pricing, reimbursement, and government contracting 
  • Criminal, civil, and internal investigations and follow-on litigation involving Anti-Kickback, Physician Self-Referral investigations, healthcare fraud, and the False Claims Act, Foreign Corrupt Practices Act, and other criminal antibribery laws

Areas of Focus

Our Team

Connect with our team.

Reach out to hear more about our practice—and discover how we can help advance your goals.

Our Work

Who We Serve

Pharmaceuticals, Biotechnology, Medical Devices, Veterinary, Agricultural & Industrial Life Sciences, Nonprofit & Academic Research Organizations, CROs & CMOs, Investment Firms & Venture Capital, Lending Institutions

Our Insight